What is LOPJLB’s current signal on AVTX?

LOPJLB’s latest quantitative signal on Avalo Therapeutics, Inc. (AVTX) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is AVTX in?

Avalo Therapeutics, Inc. (AVTX) is currently classified in the CRISIS HMM market regime on LOPJLB.

Where is Avalo Therapeutics, Inc. based / listed?

Avalo Therapeutics, Inc. is based in US, listed on NASDAQ.

Avalo Therapeutics, Inc. (AVTX)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$13.43-1.10%Close

SELLCRISIS · day 21

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $152M
Beta: 0.79
P/E (TTM): -2.87

Short % float: 119.26%
Days to cover: 13.2
SI change: +4.3%

1W: -10.17%
1M: -26.25%

vs SPY 1W: -11.72%
vs SPY 1M: -28.01%

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Avalo Therapeutics, Inc. is a precision medicine company in the clinical development phase, dedicated to identifying, advancing, and marketing specialized treatments for patients experiencing critical unmet medical needs across the fields of immunology, immuno-oncology, and…

Employees: 33
Headquarters: US
Founded: 2015
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 11.3M
Float: 96.0%

avalotx.com ↗

Key executives

Garry A. Neil — President, Chief Executive Officer & Director

Mittie Doyle FACR — Chief Medical Officer

Christopher Ryan Sullivan — Chief Financial Officer & Head of Investor relations

SEC filings

EDGAR · CIK 15341200 · AVTX

Analyst consensus

Buy

Bullish880.0%

Neutral110.0%

Bearish110.0%

L $30.00Avg $44.71H $60.00

Target$44.71+232.91%

Last$13.43

Key stats

Industry peers

Prediction markets

Company news